Tutorial on non inferiority trial in pharmaceutical research: an important and applied issue

SAUDI PHARMACEUTICAL JOURNAL · Published 2026-05-06 · DOI 10.1007/s44446-026-00077-z

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s44446-026-00077-z

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy · SAUDI PHARMACEUTICAL JOURNAL · 2026 · Same journal
Coaxial electrospun fibers for control release of vancomycin and diclofenac in osteomyelitis management · SAUDI PHARMACEUTICAL JOURNAL · 2025 · Same journal
Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges · SAUDI PHARMACEUTICAL JOURNAL · 2025 · Same journal
Assessment of the feasibility of including community pharmacies under the regulation of the saudi food and drug authority · SAUDI PHARMACEUTICAL JOURNAL · 2025 · Same journal
Phytochemical profiling and antidiarrheal activity of Sophora japonica L. fruit extract · SAUDI PHARMACEUTICAL JOURNAL · 2026 · Same journal
Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis · SAUDI PHARMACEUTICAL JOURNAL · 2025 · Same journal
Botulinum neurotoxin: from molecular pathogenesis to emerging countermeasures · SAUDI PHARMACEUTICAL JOURNAL · 2026 · Same journal
Empagliflozin improves renal injury of diabetic nephropathy complicated with hyperuricemia through AMPK by promoting autophagy and inhibiting apoptosis · SAUDI PHARMACEUTICAL JOURNAL · 2026 · Same journal
Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation · SAUDI PHARMACEUTICAL JOURNAL · 2025 · Same journal
Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs · SAUDI PHARMACEUTICAL JOURNAL · 2026 · Same journal